NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

TB & Outbreaks Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB & Outbreaks Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Leishmaniasis



Research data from University of Jordan update understanding of leishmaniasis



May 13th, 2008

"Antileishmanial chemotherapy can have adverse effects and may fail to cure patients with cutaneous leishmaniasis(CL) (CL). To evaluate the efficacy of a weekly cryotherapy regimen in patients with confirmed Leishmania major infection," researchers in Amman, Jordan report.

"One hundred twenty Jordanian patients with 375 lesions were treated with cryotherapy performed once weekly in I to 7 sessions. This regimen was adopted since living parasites were recovered, in several CL patients, even after 3 cryosessions. Scarring, vas assessed in 78 patients 3 years after treatment. Approximately 84% of the lesions were cured after 1 to 4 sessions. The remaining lesions (16.3%)...


Source: TB & Outbreaks Week (2008-05-13)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login